600 related articles for article (PubMed ID: 8403814)
41. [The late results of treating membranous glomerulonephritis].
Belovezhdov N; Robeva R; Dimitrova V
Vutr Boles; 1990; 29(3):53-60. PubMed ID: 2284800
[TBL] [Abstract][Full Text] [Related]
42. [Nephrotic syndrom with focal and segmental glomerulosclerosis in Dakar: epidemiological and clinicopathological characteristics (about 134 cases)].
Niang A; Dial C; Ka EF; Lèye A; Pouye A; Ka MM; Mbengue M; Droz D; Diouf B
Dakar Med; 2008; 53(1):45-51. PubMed ID: 19102117
[TBL] [Abstract][Full Text] [Related]
43. [Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy].
Branten AJ; Wetzels JF
Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2832-8. PubMed ID: 10065257
[TBL] [Abstract][Full Text] [Related]
44. [Prognosis of nephrosis].
Habib R; Kleinknecht C; Gubler MC; Levy M; Guillot M; Gagnadoux MF; Broyer M
Bol Med Hosp Infant Mex; 1981; 38(3):447-55. PubMed ID: 7271976
[TBL] [Abstract][Full Text] [Related]
45. A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome.
Bazzi C; Petrini C; Rizza V; Arrigo G; D'Amico G
Kidney Int; 2000 Oct; 58(4):1732-41. PubMed ID: 11012907
[TBL] [Abstract][Full Text] [Related]
46. Distribution of pathologic findings in individuals with nephrotic proteinuria according to serum albumin.
Gupta K; Iskandar SS; Daeihagh P; Ratliff HL; Bleyer AJ
Nephrol Dial Transplant; 2008 May; 23(5):1595-9. PubMed ID: 18065791
[TBL] [Abstract][Full Text] [Related]
47. Safety and tolerability of cyclosporin A (Sandimmun) in idiopathic nephrotic syndrome. Collaborative Study Group of Sandimmun in Nephrotic Syndrome.
Clin Nephrol; 1991; 35 Suppl 1():S48-60. PubMed ID: 1860268
[TBL] [Abstract][Full Text] [Related]
48. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
Ponticelli C; Zucchelli P; Passerini P; Cesana B
N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953
[TBL] [Abstract][Full Text] [Related]
49. [Advances in the treatment of adult nephrotic syndrome].
Yokoyama H; Asaka M; Yamaya H; Wada T
Nihon Jinzo Gakkai Shi; 2007; 49(2):108-12. PubMed ID: 17375618
[No Abstract] [Full Text] [Related]
50. IgG subclass composition of monomeric and polymeric IgG in the serum of patients with nephrotic syndrome.
Aro M; Hardwicke J
Clin Nephrol; 1984 Nov; 22(5):244-52. PubMed ID: 6518674
[TBL] [Abstract][Full Text] [Related]
51. [Relapsing nephrotic syndrome in a diabetic patient with minimal change].
García Donaire JA; Manzanera MI; Valentín MO; Espejo B; Gutiérrez Martínez E; Praga M
Nefrologia; 2004; 24(2):179-82. PubMed ID: 15219093
[TBL] [Abstract][Full Text] [Related]
52. Effect of pituitary microsurgery on acromegaly complicated nephrotic syndrome with focal segmental glomerulosclerosis: report of a rare clinical case.
Yoshida H; Akikusa B; Saeki N; Hasegawa S; Iesato K; Yamamoto S; Murotani N; Wakashin M; Shimada T
Am J Kidney Dis; 1999 Jun; 33(6):1158-63. PubMed ID: 10352207
[TBL] [Abstract][Full Text] [Related]
53. Treatment of steroid-resistant nephrotic syndrome with cyclosporine: study of 17 cases and a literature review.
Frassinetti Castelo Branco Camurça Fernandes P; Bezerra Da Silva G; De Sousa Barros FA; Costa Oliveira CM; Kubrusly M; Evangelista JB
J Nephrol; 2005; 18(6):711-20. PubMed ID: 16358229
[TBL] [Abstract][Full Text] [Related]
54. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
Chun MJ; Korbet SM; Schwartz MM; Lewis EJ
J Am Soc Nephrol; 2004 Aug; 15(8):2169-77. PubMed ID: 15284302
[TBL] [Abstract][Full Text] [Related]
55. Idiopathic membranous nephropathy: diagnosis and treatment.
Fervenza FC; Sethi S; Specks U
Clin J Am Soc Nephrol; 2008 May; 3(3):905-19. PubMed ID: 18235148
[TBL] [Abstract][Full Text] [Related]
56. Vascular hyperpermeability in nephrotic edema.
Rostoker G; Behar A; Lagrue G
Nephron; 2000 Jul; 85(3):194-200. PubMed ID: 10867533
[TBL] [Abstract][Full Text] [Related]
57. Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology.
Meyrier A; Condamin MC; Broneer D
Clin Nephrol; 1991; 35 Suppl 1():S37-42. PubMed ID: 1860266
[TBL] [Abstract][Full Text] [Related]
58. Remissions and relapses in idiopathic membranous nephropathy.
Ponticelli C; Passerini P; Altieri P; Locatelli F; Pappalettera M
Nephrol Dial Transplant; 1992; 7 Suppl 1():85-90. PubMed ID: 1337188
[TBL] [Abstract][Full Text] [Related]
59. Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis.
Heering P; Braun N; Müllejans R; Ivens K; Zäuner I; Fünfstück R; Keller F; Krämer BK; Schollmeyer P; Risler T; Grabensee B;
Am J Kidney Dis; 2004 Jan; 43(1):10-8. PubMed ID: 14712422
[TBL] [Abstract][Full Text] [Related]
60. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations.
Cattran DC; Alexopoulos E; Heering P; Hoyer PF; Johnston A; Meyrier A; Ponticelli C; Saito T; Choukroun G; Nachman P; Praga M; Yoshikawa N
Kidney Int; 2007 Dec; 72(12):1429-47. PubMed ID: 17898700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
